ES2076865A1 - Nuevos derivados de n-aril- y n-heteroaril-urea como inhibidores de acil-coenzima a: colesterol acil transferasa (acat). - Google Patents

Nuevos derivados de n-aril- y n-heteroaril-urea como inhibidores de acil-coenzima a: colesterol acil transferasa (acat).

Info

Publication number
ES2076865A1
ES2076865A1 ES09301508A ES9301508A ES2076865A1 ES 2076865 A1 ES2076865 A1 ES 2076865A1 ES 09301508 A ES09301508 A ES 09301508A ES 9301508 A ES9301508 A ES 9301508A ES 2076865 A1 ES2076865 A1 ES 2076865A1
Authority
ES
Spain
Prior art keywords
acyl
acat
inhibitors
heteroaryl
urea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09301508A
Other languages
English (en)
Other versions
ES2076865B1 (es
Inventor
Ernest S Hamanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Priority to ES9301508A priority Critical patent/ES2076865B1/es
Publication of ES2076865A1 publication Critical patent/ES2076865A1/es
Application granted granted Critical
Publication of ES2076865B1 publication Critical patent/ES2076865B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN COMPUESTO DE FORMULA I, SUS SALES FARMACEUTICAMENTE ACEPTABLES, EN DONDE Q, R17, R18 Y R1 SON COMO HAN QUEDADO DEFINIDOS EN LA MEMORIA. LOS COMPUESTOS DE FORMULA I SON INHIBIDORES DE LA ACIL-COENZIMA A: COLESTEROL ACIL-TRANSFERASA (ACAT) Y SON UTILES COMO AGENTES HIPOLIPIDEMICOS Y ANTIARTERIOSCLEROSIS.
ES9301508A 1993-07-05 1993-07-05 Nuevos derivados de n-aril- y n-heteroaril-urea como inhibidores de acil-coenzima a: colesterol acil transferasa (acat). Expired - Fee Related ES2076865B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9301508A ES2076865B1 (es) 1993-07-05 1993-07-05 Nuevos derivados de n-aril- y n-heteroaril-urea como inhibidores de acil-coenzima a: colesterol acil transferasa (acat).

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9301508A ES2076865B1 (es) 1993-07-05 1993-07-05 Nuevos derivados de n-aril- y n-heteroaril-urea como inhibidores de acil-coenzima a: colesterol acil transferasa (acat).

Publications (2)

Publication Number Publication Date
ES2076865A1 true ES2076865A1 (es) 1995-11-01
ES2076865B1 ES2076865B1 (es) 1996-08-01

Family

ID=8282452

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9301508A Expired - Fee Related ES2076865B1 (es) 1993-07-05 1993-07-05 Nuevos derivados de n-aril- y n-heteroaril-urea como inhibidores de acil-coenzima a: colesterol acil transferasa (acat).

Country Status (1)

Country Link
ES (1) ES2076865B1 (es)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0384320A1 (en) * 1989-02-17 1990-08-29 Warner-Lambert Company Antihyperlipidemic and anti-atherosclerotic trisubstituted urea compounds
EP0399422A1 (en) * 1989-05-25 1990-11-28 Takeda Chemical Industries, Ltd. Benzocycloalkane derivatives and production thereof
WO1991013871A1 (en) * 1990-03-12 1991-09-19 Yamanouchi Pharmaceutical Co., Ltd. Monourea derivative and its salt
EP0477778A2 (en) * 1990-09-25 1992-04-01 Eisai Co., Ltd. Benzene, pyridine and pyrimidine derivative
EP0512570A1 (en) * 1991-05-10 1992-11-11 Fujisawa Pharmaceutical Co., Ltd. Urea derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
WO1993024458A1 (en) * 1992-05-28 1993-12-09 Pfizer Inc. New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (acat)

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0384320A1 (en) * 1989-02-17 1990-08-29 Warner-Lambert Company Antihyperlipidemic and anti-atherosclerotic trisubstituted urea compounds
EP0399422A1 (en) * 1989-05-25 1990-11-28 Takeda Chemical Industries, Ltd. Benzocycloalkane derivatives and production thereof
WO1991013871A1 (en) * 1990-03-12 1991-09-19 Yamanouchi Pharmaceutical Co., Ltd. Monourea derivative and its salt
EP0477778A2 (en) * 1990-09-25 1992-04-01 Eisai Co., Ltd. Benzene, pyridine and pyrimidine derivative
EP0512570A1 (en) * 1991-05-10 1992-11-11 Fujisawa Pharmaceutical Co., Ltd. Urea derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
WO1993024458A1 (en) * 1992-05-28 1993-12-09 Pfizer Inc. New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (acat)

Also Published As

Publication number Publication date
ES2076865B1 (es) 1996-08-01

Similar Documents

Publication Publication Date Title
CA2134359A1 (en) New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
CA2260337A1 (en) Therapeutic agents
HK1026909A1 (en) Substituted phenyl derivatives, their preparation and use
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
RS49688B (sr) Novi derivat 3-aril-2- hidroksipropionske kiseline (i)
MY119150A (en) Azetidine derivatives, their preparation and medicaments containing them
CA2205757A1 (en) Pyridazinone derivatives and their use as inhibitors of prostaglandin g/h synthase i and ii(cox i and ii)
WO1999024022A3 (en) Isoquinoline derivatives for treating disorders associated with 5ht7 receptors
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
DK0883405T3 (da) Aminoproteaseinhibitorer
WO2000005214A3 (en) Isoquinolines as urokinase inhibitors
BG104447A (en) Biphenylamidine derivatives
MY129292A (en) Antivirals
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
ES2076865A1 (es) Nuevos derivados de n-aril- y n-heteroaril-urea como inhibidores de acil-coenzima a: colesterol acil transferasa (acat).
GEP20063758B (en) Benzothia(Dia)Zine Derivatives and Method for Their Use as AMPA Modulators
WO1999038841A8 (en) Adamantanecarboximidamide derivatives and their use as nmda antagonists
FI964278A0 (fi) Menetelmä 5,6-dihydroksi-2-amino-1,2,3,4-tetrahydronaftaleenin johdannaisten valmistamiseksi
BG105252A (en) Isoquinolines as urokinase inhibitors
TW358809B (en) Phenylamidinothiophene compound and anti-inflammatory agent containing the same
IL138373A0 (en) New compounds
TW329388B (en) Intraocular irrigating solution
DK0777471T3 (da) Inhibering af leukotrienbiosynese med urinstofderivater
SI0937075T1 (en) New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19930705

Kind code of ref document: B1

Effective date: 19930705

FD1A Patent lapsed

Effective date: 20040503